Tiagabine (Epilepsy = All indications)

Study	Exclusion reasons	Rmk	Reference
Vajda b (Tiagabine) (Epilepsy), 2024	same data already obtained by other studies	EXCLUDED: Partial overlapping with Vajda 2019 (same number of exposed pregnancies and more relevant period of exposure) => Use of Vajda 2019.